Development of liposomal anticancer drugs

Area of Science:

• Pharmaceutical Sciences
• Drug Delivery Systems
• Nanotechnology

Background:

• Liposomes are advanced drug delivery systems with the potential to improve the therapeutic efficacy of anticancer agents.
• Adverse effects of conventional chemotherapy limit treatment effectiveness; liposomal formulations offer a strategy to enhance tumor accumulation via the enhanced permeability and retention effect.
• Developing liposomal anticancer agents requires careful formulation design to ensure stability and maximize clinical potency.

Purpose of the Study:

• To review the development process of liposomal anticancer drug products.
• To highlight the importance of chemical and physicochemical stability in liposomal formulation design.
• To emphasize the critical role of drug release rates and the need for reliable analytical methods for quality assurance.

Main Methods:

• Discussion of liposomal formulation design principles focusing on stability and drug release kinetics.
• Introduction of analytical techniques, specifically column-switching High-Performance Liquid Chromatography (HPLC) with online solid-phase extraction, for evaluating liposomal drug products.
• Review of methods for in vitro release testing and in vivo pharmacokinetic evaluation.

Main Results:

• Liposomal formulations can improve the pharmacokinetic profile of anticancer drugs, leading to enhanced tumor accumulation and reduced toxicity.
• Chemical and physicochemical stability of liposome ingredients are crucial for drug product quality and therapeutic performance.
• Accurate analytical methods are essential for determining drug release and concentration in biological fluids, enabling reliable in vitro and in vivo assessments.

Conclusions:

• Liposomal drug product development necessitates a comprehensive approach, integrating formulation stability, controlled drug release, and robust analytical methodologies.
• Effective liposomal anticancer agents require precise control over drug release dynamics to ensure stability in circulation and prompt release at the tumor site.
• Column-switching HPLC offers a reliable analytical solution for quality control and pharmacokinetic studies of liposomal drug products, supporting their successful clinical translation.